Printing And Publishing Tenders

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Open House Contracts for Multiple Active Ingredients/Active Ingredient Combinations

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Oh-Biologika-2023-14 - Insulin Isophane/Insulin, Normal (Human) (Combination of Active Ingredients) (Dosage Form: Cylinder Ampoules)

Open House Discount Contracts 2022-20

Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Piribedil (Atc Code: N04bc08).

Open House Discount Contracts 2023-01

Conclusion of a Non-Exclusive Discount Agreement in Accordance with § 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Octreotide, in a Dosage Form with Delayed Release Behavior Atc Code: H01cb02

Oh-Biologika-2023-13 - Insulin Isophane (Human) (Dosage Form: Cylinder Ampoules)

Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Sapropterin (Atc Code: A16ax07).